Delivery Order SPE2DB25D3005-SPE2DB25FQJHT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,054.76 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections) with a ceiling value of $16,198.68. This firm fixed-price delivery order, which is due for completion by August 8, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award utilized no set-aside designation and was competitively awarded. The pharmaceutical...
- The Defense Logistics Agency awarded a $7,201.22 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections. This firm fixed-price contract, with a completion date of September 2, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award involved no set-aside designation and was competitively awarded....
- The Defense Logistics Agency awarded a $1,833.32 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award is not set-aside and was competitively awarded, reflecting the contractor's...
- The Defense Logistics Agency awarded a $7,804.29 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). This contract represents a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. As a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- AmerisourceBergen Drug Corp was awarded a $54,516.23 delivery order contract by the Defense Logistics Agency on July 22, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injections). The contract is set to be completed by July 23, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,087.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) under a firm fixed-price contract. This non-set-aside award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a single delivery transaction for pharmaceutical supplies to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). The contract, valued at $2,601.43, is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $11,404.44 to AmerisourceBergen Drug Corp for the supply of FORTEO 560 MCG/2.24 ML pen injections on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to the company's corporate office location in...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQJHTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,833.32 on September 3, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract is set to complete by September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a routine pharmaceutical procurement within AmerisourceBergen's established relationship with federal medical supply chains. This award is part of AmerisourceBergen's comprehensive pharmaceutical supply relationship with DLA, supported by the company's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen serves as a critical vendor for military and veteran healthcare systems, supplying a broad range of pharmaceutical products, medical devices, and healthcare commodities. The delivery order for Forteo, a bone density medication, exemplifies the company's role in supporting federal health procurement across multiple therapeutic domains for the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/3/25 |